Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jul 16;7(1):239.
doi: 10.1038/s41392-022-01100-0.

Epstein-Barr virus infection: the leading cause of multiple sclerosis

Ruirui He #  1   2 , Yanyun Du #  3   4 , Chenhui Wang  5   6
Affiliations
Comment

Epstein-Barr virus infection: the leading cause of multiple sclerosis

Ruirui He et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Schematic illustration of the study. Samples from 955 MS case and 1843 controls were randomly selected in the following experiments. Individuals were assessed for EBV and CMV status by three serum samples per person. Serum sNfL levels were measured before, around, and after the time of EBV infection in individuals whose first serum sample was EBV-negative. Virome analysis of serum samples from 30 MS cases and 30 match was made by VirScan. These experiments suggest that EBV is the leading cause of multiple sclerosis
See this image and copyright information in PMC

Comment on

References

    1. Bjornevik K, et al. Longitudinal analysis reveals high prevalence of Epstein–Barr virus associated with multiple sclerosis. Science. 2022;375:296–301. doi: 10.1126/science.abj8222. - DOI - PubMed
    1. International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365:6460. doi: 10.1126/science.aav7188. - DOI - PMC - PubMed
    1. Bar-Or A, et al. Epstein–Barr virus in multiple sclerosis: theory and emerging immunotherapies. Trends Mol. Med. 2020;26:296–310. doi: 10.1016/j.molmed.2019.11.003. - DOI - PMC - PubMed
    1. Levin LI, et al. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA. 2005;293:2496–2500. doi: 10.1001/jama.293.20.2496. - DOI - PubMed
    1. Hauser SL, et al. Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis. N. Engl. J. Med. 2017;376:221–234. doi: 10.1056/NEJMoa1601277. - DOI - PubMed

Publication types

MeSH terms